NASA continues building next-gen Roman Space Telescope despite budget worries
When you buy through links on our articles, Future and its syndication partners may earn a commission.
NASA engineers have successfully completed testing on one half of the Nancy Grace Roman Space Telescope — a key step in making sure this future observatory will perform as expected once it reaches space.
"This milestone tees us up to attach the flight solar array sun shield to the outer barrel assembly, and deployable aperture cover, which we'll begin this month," said Jack Marshall, who leads integration and testing for these Roman Space Telescope elements at NASA's Goddard Space Flight Center in Greenbelt, Maryland.
"Then we'll complete remaining environmental tests for the flight assembly before moving on to connect Roman's two major assemblies and run the full observatory through testing, and then we'll be ready to launch!" he continued.
Launch is expected to occur sometime in early 2027. That timeline, however, could still be up in the air as the White House plans to slash NASA's budget in 2026. The drastic 24% cut — the largest in NASA's history — would affect major projects like the Gateway moon-orbiting space station and Mars sample return, among others. Previously released "passback documents," which also describe possible White House fiscal year budget scenarios, suggested funding will be given for the Hubble Space Telescope and James Webb Space Telescope but not other telescopes. However, the agency is still awaiting a finalized budget.
For now, engineers are continuing their work on Roman. Back in January, before thermal testing could begin, engineers attached the telescope's visor-like sunshade called the "deployable aperture cover" to the telescope's outer barrel assembly, which will eventually house its powerful instruments. By March, they'd also added a set of test solar panels.
In April, this entire setup was moved into the Space Environment Simulator at NASA's Goddard Space Flight Center in Maryland — a giant chamber that mimics the harsh hot-and-cold temperatures Roman will face in space. Of note, those aforementioned passback documents had reportedly suggested the White House's possible cuts to NASA funding could see Goddard Space Flight Center shut down entirely.
Related Stories:
— NASA installs 'bulletproof' sunshade on powerful Nancy Grace Roman Space Telescope (photos)
— Trump's 2026 budget plan would cancel NASA's Mars Sample Return mission. Experts say that's a 'major step back'
— Experts alarmed as White House proposes 'largest single-year cut to NASA in American history'
"The test verifies the instruments will remain at stable operating temperatures even while the sun bakes one side of the observatory and the other is exposed to freezing conditions — all in a vacuum, where heat doesn't flow as readily as it does through air," said Jeremy Perkins, an astrophysicist serving as Roman's observatory integration and test scientist at NASA Goddard.
Once Roman is out in orbit nearly a million miles from Earth, there's no easy way to send astronauts to fix it. That's why NASA engineers work tirelessly to make sure everything deploys and operates flawlessly. No second chances.
Technicians are gearing up to connect Roman's two main sections this November. Once joined, the telescope will officially become a fully assembled observatory by the end of the year. After final testing is complete, Roman will be packed up and shipped to NASA's Kennedy Space Center in Florida to begin launch preparations in summer 2026.
NASA scientists say the mission remains on schedule, though they are working hard toward the possibility of an even earlier liftoff as soon as fall 2026.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Miami Herald
19 minutes ago
- Miami Herald
Axiom Space's record-setter to lead astronauts from 3 nations on private mission
Peggy Whitson has spent nearly two years of her life in space as an Axiom Space employee and former NASA astronaut. Next week she'll lead a mission with three men representing countries that haven't sent anyone to space in more than four decades. Whitson, 65, will command the Ax-4 mission targeting liftoff as early as 8:22 a.m. Tuesday from Kennedy Space Center's Launch Pad 39-A. It will transport three Axiom customers: one each from India and Hungary, whose seats were paid for by their governments, and one from Poland through the European Space Agency. Whitson flew three times for NASA before joining Axiom, for which she commanded the Ax-2 mission in 2023 and tallied more than 675 days in space. She holds the record for most time in space by a woman and most for any American. All four of her missions were to the International Space Station - as is the Ax-4 flight. "For me, returning to space is always a special experience. Every mission is different," she said during a call with media Tuesday. "Every crew brings something new to the table. I've been incredibly impressed by the dedication and the work ethic and the passion of this team. "It's been a joy to train alongside them and I'm looking forward to seeing them in microgravity." That crew members are Shubhanshu Shukla of India, acting as mission pilot; mission specialist Sławosz Uznański of Poland, an ESA project astronaut; and mission specialist Tibor Kapu of Hungary. The quartet will climb aboard a new SpaceX Crew Dragon - which will get its official name once it reaches orbit - launching atop a Falcon 9 rocket on only the second human spaceflight of the year from Space Coast following the March launch of Crew-10. The Dragon is slated to dock with the space station Wednesday at 12:30 p.m. for a planned two-week stay during which crew members will participate in a heavy schedule of science experiments, technology demonstrations and media outreach. "We'll be conducting research that spans biology, material and physical sciences as well as technology demonstrations," Whitson said. "We'll also be engaging with students around the world, sharing our experience and inspiring the next generation of explorers." One science experiment she's most interested in could pave the way for people who are diabetic to travel into space. "A person with diabetes can't fly in space because it's disqualifying and not considered to be safe, because we wouldn't know how their bodies would respond," Whitson said. "So if we have the appropriate technology to monitor the individuals, we feel that we can open up that door and that path for a lot of folks in the world and just open up space a little bit more." Delving into a customer base of countries which don't have as much access to space is part of Axiom's business plan. For this mission, the three countries represented first flew to space with the Soviet Union as cosmonauts on Soyuz spacecraft, but nothing since 1984, although a Hungarian-American millionaire flew to the space station twice as a tourist in 2007 and 2009. The governments paid Axiom an undisclosed amount for their representatives' trip to the space station. It marks the third time it has flown government-sponsored passengers after its first trip to the station in 2022 had three men who paid $55 million each for their visit. Whitson's last trip on Ax-2 had just one private passenger who paid their own way. The Saudi Arabian government paid for the other two passengers. Since then, Axiom has focused on only government-sponsored customers. Ax-3 in 2024 had passengers from Italy, Turkey and Sweden. Similar to Uznański on this mission, the ESA paid for the Swedish customer even though the agency has access to the space station as a partner with NASA, Canada, Japan and Russia. The trio of space newcomers on this mission all spoke of it as opening up possibilities for their nations. "I carry with me, not just instruments and equipment, but the hopes and dreams of a billion hearts," said India's Shukla, who will perform seven experiments for research institutions from his nation. "These experiments will pave the way for India's progress in microgravity science, and I'm proud to be the bridge between Earth and orbit for this pioneering research, balancing the scientific ambition with a rich cultural heritage." Poland's Uznański noted that he will enjoy the view. "I'm looking forward to floating in the cupola, which is our window back on Earth. I can't wait to see all the training places, and also our four countries from up there, but mostly to see Earth as a whole, as one planet, one home," he said. Kapu will do 25 experiments for Hungary while also using half of his personal luggage space to bring something that pays homage to the first Hungarian who flew to space in 1978. "There was a teddy bear which is wearing a cosmonaut space suit. This teddy bear is from a Hungarian TV show for kids," he said, noting it went along for the ride nearly 50 years ago. "I'm really proud to fly that again." It won't be the only stuffed animal on the flight. The other is a swan called Joy, named by Kapu, that will function as the crew's "zero-gravity indicator" - traditionally an object that lets astronauts know they've reached space as it begins to float around after launch. Whitson teased the swan's connection to the name reveal for the Crew Dragon capsule. The first four Crew Dragons were named Endeavour, Resilience, Endurance and Freedom. "The reason we selected this one might become more obvious once you hear the name of the vehicle," she said. "You'll have to wait for that one." -------------- Copyright (C) 2025, Tribune Content Agency, LLC. Portions copyrighted by the respective providers.


Medscape
an hour ago
- Medscape
Medscape at 30: Three Decades of Amazing Breakthroughs
Medscape turns 30 in 2025. As part of the Medscape 2050 project speculating on what the field will look like 25 years from now, we're looking back at medical history as told through Medscape news coverage. A walk down memory lane, for sure, but also a celebration of the breakthroughs, headlines, and reporting that helped define medicine since 1995. July 5, 1996: Dolly the Sheep Cloned The birth of the first cloned animal led to some interesting cloning coverage over the years, whether from claims of a cloned human baby, ethical concerns surrounding human cloning, and advances in animal cloning as more than just a curiosity: Single Genetic Difference May Make Humans Easier to Clone Knockout Pigs Heralded as Future Organ Source FDA: Meat of Cloned Animals Safe to Eat 1998: Discovery of Human Embryonic Stem Cells A groundbreaking and polarizing discovery. Just over a year later, Medscape would look at the fallout, and advances would attempt to eliminate ethical concerns by tricking mouse and human cells to exhibit all the traits of embryonic stem cells. Coverage would span many conditions over the years: Is New Stem Cell Research Major Step Toward Diabetes Cure? Stem Cell Therapy Among Hot Topics at AAO 2017 Promising New Data on Stem Cell Therapy for Parkinson's 1997: da Vinci Robotic Surgical System Begins Development Minimally invasive robotic surgery via the da Vinci system was approved by the FDA in 2000, and by 2011, it was in use in more than 2000 hospitals around the world. Between 2011 and 2012, however, adverse event reports rose 34%, prompting this detailed Medscape slideshow, Robotic Surgery: Too Much, Too Soon? 2000: First Draft of the Human Genome Announced It wasn't perfect, it had gaps and wasn't fully understood, but the turn of the century marked the first map of the human genome, paving the way for what we now see as precision and personalized medicine. In 2020, Medscape commissioned a thorough charting of the genome over its first 20 years to see what grew from that first announcement. Early 2000s: Rise of Direct-to-Consumer (DTC) Genetic Testing (eg, 23andMe) Inexpensive genetic testing led to the advent of offering tests to consumers, and the most famous purveyor, 23andMe, debuted in 2006. This marked a shift in how people access and interpret genetic data — and raised concerns. It's been a bumpy ride: Ethical Considerations in DTC Genetic Testing 23andMe Relaunches Lower-Risk DTC Genetic Tests FDA OK's First DTC Genetic Risk Tests 23andMe Notifies Customers of Data Breach Into Its 'DNA Relatives' Feature 23andMe's Business Woes Raise Genetic Data Privacy Concerns: Ethicist 2009: Electronic Health Record (EHR) Adoption Incentivized by HITECH Act EHRs, now ubiquitous, started slow in 2009, with one report estimating adoption in US hospitals at less than 2%. All that changed of course, with Medscape eventually releasing annual reports on physicians and EHRs. And in 2024, we even asked if physicians should be compensated for their time using EHRs. Don't Get Too Hung Up on 'Meaningful Use' in an EHR EHR Adoption Grows Rapidly in Office-Based Physician Groups 2012: CRISPR-Cas9 Gene Editing Discovered 2016: First CRISPR Clinical Trial in Humans Gene editing, and the ethical arguments that went with it, took the medical world by storm a little over a decade ago. Medscape has been covering its potential therapeutic (and controversial) applications ever since including the 2018 birth of 'gene-edited babies' in China. 5 Things to Know About CRISPR New CRISPR Tools More Precise, but Targeting Mishaps a Worry CRISPR Gene Editing in Limelight at ASHG 2016 Bioethicist: History Tells Us CRISPR Fears Are Overblown 2016: Semaglutide Shows Superior Glucose Control and Weight Loss in SUSTAIN-6 Trials The hype begins. Not only shown effective for glucose control, semaglutide also demonstrated marked cardiovascular risk reduction in 2016. While that was nearly 10 years ago, it feels like we haven't had a day without GLP-1 news since. Oral GLP-1 Agonists Could Be Game Changers for Obesity Treating Obesity: Will New Miracle Drugs End the Crisis? GLP-1s Treat and Even Reverse Some Forms of Liver Disease GLP-1 Agonists Reduce Recurrent Atrial Fibrillation July-October 2017: CAR T-Cell Therapy Approved for Leukemia The FDA approved tisagenlecleucel-T (Kymriah, Novartis) and soon after a xicabtagene ciloleucel (Yescarta, Kite Pharma), the first two CAR T-cell therapies in 2017, opening the door for personalized cancer treatment and further progress beyond treating blood cancers. CARs Motor Through Leukemia, Part 2: 'Landscape Changing' CAR T Cells and Beyond: Breakthroughs and Challenges Ahead Outpatient CAR T: Safe, Effective, Accessible Next-Gen CAR T-Cell Therapy: Expanding Beyond Blood Cancers December 2020: mRNA Vaccines Approved After effectiveness of the Pfizer and Moderna COVID vaccines was documented, the FDA granted emergency use of both vaccines within a week of each other. This opened the door for further mRNA usage, including potential cancer vaccines. 4 Things to Know About Moderna's mRNA Cancer Vaccine New mRNA Vaccines in Development for Cancer and Infections 'Encouraging' Early Data for mRNA Vaccine in Glioblastoma New mRNA Vaccine May Shield Against C difficile Infections 2023: FDA Approvals in Medical Artificial Intelligence (AI), Especially Diagnostics, Increase While AI was not invented in 2023, that year became a tipping point in everything AI — from diagnostics to drug development to medical scribes, inspiring the first Medscape Physicians and AI Report, done annually since. A sampling of the flood of Medscape coverage: Minding the Machine: Assessing the Case for AI Regulations in Healthcare Harnessing FDA-Approved AI Technologies in Your Medical Practice The Protein Problem: The Unsolved Mystery of AI Drug Dev This Bill Could Make It Legal for AI to Prescribe Medicine AI vs Physicians in 2050: Happy Future or No Future?
Yahoo
an hour ago
- Yahoo
Why does NASA's Perseverance rover keep taking pictures of this maze on Mars?
When you buy through links on our articles, Future and its syndication partners may earn a commission. If you've spent any time perusing the carousel of raw images from NASA's Perseverance Mars rover, you might have stumbled across an odd subject: a tiny, intricate maze etched into a small plate, photographed over and over again. Why is the Perseverance rover so obsessed with this little labyrinth? It turns out the maze is a calibration target — one of 10 for Perseverance's Scanning Habitable Environments with Raman & Luminescence for Organics and Chemicals instrument, otherwise known for its fun acronym, SHERLOC. This Sherlock Holmes–inspired tool is designed to detect organic compounds and other minerals on Mars that could indicate signs of ancient microbial life. To do that accurately, the system must be carefully calibrated, and that's where the maze comes in. Located on the rover's seven-foot (2.1-meter) robotic arm, SHERLOC uses spectroscopic techniques — specifically Raman and fluorescence spectroscopy — to analyze Martian rocks. In order to ensure accurate measurements, it must routinely calibrate its tools using a set of reference materials with specific properties. These are mounted on a plate attached to the front of the rover's body: the SHERLOC Calibration Target. "The calibration targets serve multiple purposes, which primarily include refining the SHERLOC wavelength calibration, calibrating the SHERLOC laser scanner mirror, and monitoring the focus and state of health of the laser," Kyle Uckert, deputy principal investigator for SHERLOC at NASA's Jet Propulsion Laboratory, tells The target is arranged in two rows, each populated with small patches of carefully selected materials. The top row includes three critical calibration materials: aluminum gallium nitride (AlGaN) on sapphire discs; the UV-scattering material Diffusil; and Martian meteorite SaU008, whose mineral makeup is already known and helps align wavelength calibration with real Martian geology. This is also where you'll find the maze. Why a maze? "SHERLOC is all about solving puzzles, and what better puzzle than a maze!" says Uckert. The purpose of the maze target is to calibrate the positioning of the laser scanner mirror and characterize the laser's focus, which requires a target with sharply contrasting spectral responses. The maze serves this purpose well." The maze is made of chrome-plated lines just 200 microns thick (about twice the width of a human hair) printed onto silica glass. "There are no repeating patterns and the spectrum of the chrome plating is distinct from the underlying silica glass," says Uckert. That makes it possible to measure the laser's focus and accuracy with extreme precision. If you look closely at the maze, you'll also notice a Sherlock Holmes portrait right at the center. While it's a cheeky nod to the instrument's name, it serves a practical function. "SHERLOC spectral maps can resolve the 200 micron thick chrome plated lines and the 50 micron thick silhouette of Sherlock Holmes at the center of the maze," Uckert notes. Like the portrait, the bottom half of the SHERLOC Calibration Target also serves a dual purpose: spectral instrument calibration and spacesuit material testing. It contains five samples of materials used in modern spacesuits, including some materials you might be familiar with, like Teflon, Gore-Tex, and Kevlar. And don't miss the "fun" target in this row — there's a geocache marker backing a polycarbonate target, and it does indeed have a tie-in to Sherlock Holmes. RELATED STORIES: — Perseverance rover's Mars samples show traces of ancient water, but NASA needs them on Earth to seek signs of life — Perseverance Mars rover finds 'one-of-a-kind treasure' on Red Planet's Silver Mountain — Perseverance Mars rover becomes 1st spacecraft to spot auroras from the surface of another world These materials are actively being tested under Mars conditions to determine how they hold up over time in situ, which is crucial for planning human exploration of the Red Planet. "Note that we use all of these materials to fine-tune SHERLOC," adds Uckert. "As a bonus, the spacesuit materials support unique science that will help keep future astronauts safe." Now, if all these Sherlock Holmes–related Easter eggs on the SHERLOC Calibration Target aren't enough for you, there's one final link. SHERLOC has a color camera as part of its instrumentation suite that sometimes images the target, and it's called the Wide Angle Topographic Sensor for Operations and eNgineering. Yes, SHERLOC's sidekick is called WATSON.